china glp 1 GLP-1 drug study suggests slim chance weight stays off after treatment Innovent's weight-loss drug highlights China

Athira Pharma's fosgonimeton (ATH-1017), part of the same HGF/c-Met program, failed the primary endpoint of its Phase 2/3 LIFT-AD Alzheimer's trial in September 2024

Researchers study BPC157 10MG in the context of connective tissue and musculoskeletal models, including tendons and ligaments, as well as gastrointestinal peptide research

While any type of physical activity is beneficial, when it comes to preserving and building muscle, resistance training is king

Med Matrix: A Leader in Regenerative Medicine At *Med Matrix*, we aim to change healthcare with new regenerative treatments

It's a gamble you shouldn't take with your health

All protocols are prescribed and monitored by Dr